Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3039114	e-akantos	% (—)	52	60	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Symptoms and signs involving the urinary system

21.59

37.71

1.2

1.0

—

All kidney diseases

15.49

30.70

1.2

1.1

—

Unspecified haematuria

45.64

25.72

1.2

1.0

—

All chronic kidney diseases

52.32

25.41

1.2

—

Renal tubulo-interstitial diseases

8.51

16.29

1.0

1.3

—

Chronic kidney disease

37.33

15.21

1.1

1.2

—

Renal failure

21.62

14.94

1.0

1.4

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4.85

7.71

1.2

1.1

—

Heart failure, not strict

7.64

7.60

1.3

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

4.21

6.37

1.1

—

Autoimmune diseases excluding thyroid diseases

4.20

6.34

1.1

—

Systemic connective tissue disorders

10.00

5.52

1.2

1.0

—

Recurrent and persistent haematuria

+∞

5.22

1.6

0.0

—

Other necrotizing vasculopathies (FG)

+∞

5.21

1.2

0.0

—

Hypertension, essential

6.10

5.07

1.4

1.0

—

Other soft tissue disorders, not elsewhere classified

3.83

5.01

1.4

1.1

—

Cardiac arrhythmias

6.00

4.52

1.4

1.2

—

Hypertensive diseases

5.64

4.52

1.1

1.0

—

Hypertension

5.64

4.52

1.1

1.0

—

Heart failure,strict

7.06

4.31

1.1

—

Pain in limb

3.75

4.22

1.4

1.1

—

Hypertensive diseases (excluding secondary)

7.26

4.19

1.1

1.0

—

Retention of urine

11.49

4.07

1.1

1.0

—

Oedema, not elsewhere classified

7.89

4.02

1.3

1.0

—

Cellulitis

10.01

4.01

1.0

1.3

—

Cardiovascular diseases (excluding rheumatic etc)

5.75

3.97

1.2

1.1

—

Gout

10.27

3.95

1.4

1.2

—

Acute bronchitis

6.30

3.91

1.3

—

Other systemic involvement of connective tissue

12.00

3.76

1.0

—

Other acute lower respiratory infections

5.02

3.66

1.3

1.2

—

ILD medications: immunosuppressive drugs

4.44

3.60

1.0

1.1

—

Haemorrhage from respiratory passages

6.56

3.57

1.0

1.5

—

Cerebrovascular diseases

4.22

3.55

1.2

—

Benign neoplasm of colon, rectum, anus and anal canal

4.34

3.50

1.4

1.1

—

Implicit Sepsis

3.77

3.49

1.1

1.2

—

Antihypertensive medication - note that there are other indications

5.30

3.40

1.2

1.1

—

Bleeding

3.70

3.39

1.1

1.2

—

Benign neoplasm: Colon

5.05

3.37

1.4

1.1

—

Other and unspecified anaemias

5.86

3.36

1.5

1.1

—

Gout, unspecified

7.00

3.36

1.4

1.2

—

Other anaemias

5.85

3.36

1.5

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.28

3.35

1.1

1.2

—

Heart failure, strict

4.70

3.32

1.1

1.3

—

Aplastic and other anaemias

5.74

3.31

1.5

1.1

—

Sleep apnoea

3.24

3.21

1.3

1.1

—

Gout, idiopatic and unspecified

6.37

3.18

1.4

1.2

—

Pain, not elsewhere classified

6.37

3.18

1.0

—

Inflammatory bowel disease treatment related agents

2.89

3.18

1.2

1.1

—

Oral corticosteroids

2.97

3.17

1.2

1.1

—

Fever of other and unknown origin

4.71

3.16

1.4

1.0

—

Polyarthropathies

3.99

3.11

1.3

1.2

—

Other heart diseases, wide

3.18

3.08

1.4

1.1

—

Diabetic nephropathy

7.41

3.02

1.0

1.6

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

4.95

3.02

1.1

1.3

—

Gout, FINNGEN

5.82

3.01

1.4

1.2

—

Endometriosis ASRM stages 3,4

10.00

2.98

1.0

1.2

—

Other heart diseases

6.53

2.97

1.1

—

Stroke, excluding SAH

4.06

2.97

1.2

—

Heart failure and bmi 25plus

8.11

2.92

1.0

1.6

—

Malaise and fatigue

4.95

2.92

1.5

1.0

—

Diverticular disease of intestine

3.70

2.90

1.1

—

Gout, strict definition

6.67

2.86

1.5

1.2

—

Pulmonary heart disease, diseases of pulmonary circulation

5.38

2.86

1.1

1.3

—

Diabetic nephropathy, excluding more controls

7.06

2.85

1.0

1.6

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

4.12

2.83

1.1

—

All-cause Heart Failure

4.24

2.80

1.1

1.3

—

Pregnancy hypertension

4.48

2.76

1.1

—

Certain disorders involving the immune mechanism

8.34

2.75

1.0

1.3

—

Coagulation defects, purpura and other haemorrhagic conditions

8.34

2.75

1.2

—

Pre-eclampsia

8.34

2.75

1.2

1.3

—

Other specified/unspecified arthritis

8.34

2.75

1.0

1.3

—

DVT of lower extremities and pulmonary embolism

4.98

2.71

1.1

1.3

—

Endometriosis of ovary

8.13

2.70

1.0

1.5

—

All influenza

6.00

2.69

1.0

1.1

—

Stroke, including SAH

3.63

2.69

1.2

—

Cardiovascular diseases

4.78

2.63

1.1

—

Metabolic disorders

2.83

2.60

1.1

1.2

—

Venous thromboembolism

4.07

2.59

1.3

—

Reimbursement for rheumatic diseases

3.32

2.58

1.0

1.2

—

STROKE

3.82

2.56

1.2

1.1

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

7.14

2.55

1.0

1.3

—

Pre-eclampsia or eclampsia

7.14

2.55

1.2

1.3

—

Pulmonary heart disease

5.45

2.54

1.2

1.4

—

Pulmonary embolism

5.45

2.54

1.2

1.4

—

Sleep apnoea, including avohilmo

2.78

2.53

1.3

1.1

—

Sleep disorders (combined)

2.62

2.52

1.4

1.0

—

Infections of the skin and subcutaneous tissue

3.43

2.45

1.0

1.2

—

Disorders of lipoprotein metabolism and other lipidaemias

3.10

2.42

1.1

1.2

—

Cervical disc disorders

5.00

2.40

1.2

1.1

—

Sequelae of cerebrovascular disease

5.18

2.40

1.2

1.3

—

ILD medications: prednisolone, methylprednisolone, prednisone

2.61

2.38

1.2

1.1

—

Other arthritis (FG)

6.25

2.37

1.0

—

Autoimmune diseases

2.64

2.36

1.4

1.1

—

Autoimmune diseases related-to ILD

2.63

2.32

1.2

—

Diseases of oesophagus, stomach and duodenum

2.54

2.31

1.3

1.1

—

General symptoms and signs

2.71

2.29

1.5

1.0

—

Nutritional anaemias

3.97

2.27

1.1

1.2

—

Influenza and pneumonia

2.47

2.25

1.1

1.2

—

Bacterial Sepsis

3.99

2.24

1.0

1.3

—

Second line medication for Crohn's disease

3.10

2.22

1.0

1.2

—

Enthesopathies of lower limb, excluding foot

5.56

2.21

1.6

1.1

—

Myalgia

5.56

2.21

1.2

1.1

—

Diseases of the skin and subcutaneous tissue

2.74

2.15

1.2

1.3

—

Diaphragmatic hernia

4.29

2.15

1.5

1.1

—

ILD medications

2.45

2.12

1.2

1.1

—

Bronchitis

2.38

2.09

1.2

1.1

—

Other and unspecified iron deficiency

5.00

2.07

1.2

1.1

—

Other arthrosis

3.73

2.06

1.1

1.2

—

Used for control exclusion in common control thyroid runs

2.53

2.04

1.4

1.1

—

Examination and observation for other reasons

3.06

2.02

1.6

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.52

2.02

1.3

1.1

—

Ischaemic Stroke, excluding all haemorrhages

3.13

1.97

1.3

1.2

—

Anxiety (asthma-related co-morbidities)

3.09

1.95

1.5

1.1

—

Chronic periodontitis, complicated

3.30

1.94

1.4

1.1

—

Dermatitis and eczema

2.28

1.92

1.1

1.2

—

Other functional intestinal disorders

3.25

1.90

1.4

1.2

—

Abnormalities of heart beat

3.68

1.89

1.0

1.4

—

Erysipelas

2.75

1.88

1.0

1.2

—

Abnormal findings on examination of blood, without diagnosis

3.67

1.88

1.0

1.3

—

In situ neoplasms

3.53

1.83

1.2

—

Implicit bacterial Sepsis

3.54

1.81

1.0

1.3

—

Insulin medication

3.10

1.79

1.1

—

Parasetamol

2.81

1.76

1.3

1.1

—

All anxiety disorders

2.75

1.73

1.5

1.1

—

L04AX Other immunosuppressants

2.67

1.72

1.0

1.2

—

First line medication for Crohn's disease

2.27

1.71

1.2

1.1

—

Hyperlipidaemia, other/unspecified

3.25

1.69

1.2

—

Chronic apical periodontitis

2.15

1.68

1.4

1.1

—

Heart failure and coronary heart disease

3.27

1.63

1.2

1.3

—

Hard cardiovascular diseases

2.48

1.63

1.2

—

Neurological diseases

2.51

1.63

1.3

1.1

—

Tramadol

2.46

1.62

1.4

1.1

—

Other retinal disorders

2.60

1.62

1.0

1.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2.78

1.62

1.1

1.2

—

Type 2 diabetes

2.26

1.61

1.4

1.1

—

Other bacterial diseases

2.24

1.61

1.0

1.2

—

Cardiodefibrillation

3.56

1.61

1.2

1.3

—

Pre-eclampsia or poor fetal growth

3.56

1.61

1.2

1.1

—

Injuries to the hip and thigh

3.02

1.57

1.0

1.3

—

Pneumonia, organism unspecified

2.34

1.56

1.2

—

Exposure to unspecified factor

2.16

1.54

1.3

1.1

—

Mouth breathing

3.33

1.52

1.2

1.3

—

2.07

1.50

1.1

—

Dental caries, including avohilmo

2.56

1.50

1.2

1.1

—

Iron deficiency anaemia

3.28

1.50

1.2

1.3

—

Other disorders of skin and subcutaneous tissue

2.50

1.49

1.0

1.2

—

Other anxiety disorders

2.74

1.41

1.2

—

Recurrent or chronic depression

3.20

1.40

1.8

1.1

—

Any death

2.51

1.40

1.0

1.3

—

Migraine

2.70

1.38

1.3

1.1

—

Erysipelas

2.65

1.37

1.0

1.3

—

Other cataract

2.67

1.35

1.0

1.3

—

Episodal and paroxysmal disorders

2.11

1.35

1.4

1.1

—

Diabetes, varying definitions

2.07

1.35

1.4

1.1

—

Finngen Rheumatological endpoints

2.16

1.35

1.5

1.1

—

Soft tissue disorders

2.18

1.34

1.5

1.1

—

Diabetes mellitus

2.06

1.34

1.4

1.1

—

Explicit Sepsis

2.92

1.33

1.2

1.3

—

Nerve, nerve root and plexus disorders

2.04

1.32

1.0

1.2

—

Depression

2.07

1.28

1.5

1.1

—

Opioids

2.12

1.26

1.5

1.1

—

Other disorders of urethra and urinary system

2.31

1.26

1.1

1.2

—

Other nutritional deficiencies

2.28

1.26

1.0

1.2

—

Myocardial infarction

2.48

1.24

1.2

1.1

—

Bacterial infection, other or unspecified

2.42

1.23

1.0

1.3

—

Mycoses

2.07

1.23

1.1

1.2

—

Acute tubulo-interstitial nephritis

2.70

1.22

1.0

1.4

—

Injuries to the elbow and forearm

2.20

1.22

1.1

1.2

—

Type 2 diabetes, wide definition

2.23

1.22

1.5

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2.40

1.21

1.7

1.1

—

Other arrhythmias

2.38

1.19

1.5

1.1

—

Other headache syndromes

2.50

1.15

1.2

1.1

—

Mood disorders, excluding more controls

1.99

1.14

1.5

1.1

—

Persons encountering health services in other circumstances

2.49

1.14

1.0

1.3

—

Other diseases of urinary system

2.08

1.14

1.1

1.2

—

Dermatitis

2.32

1.12

1.1

1.2

—

Major coronary heart disease event excluding revascularizations

2.33

1.12

1.1

1.3

—

Disorders of choroid and retina

2.03

1.11

1.0

1.2

—

Obesity due to excess calories

2.38

1.09

1.0

1.3

—

2.02

1.08

1.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.02

1.08

1.2

—

Cystitis

2.06

1.07

1.0

1.2

—

Myocardial infarction, strict

2.37

1.04

1.2

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

1.89

1.04

1.2

—

Gastrointestinal diseases

0.00

1.04

0.0

1.1

—

All pneumoniae

1.88

1.03

1.2

—

Obesity

2.05

1.02

1.0

1.2

—

Obesity and other hyperalimentation

2.04

1.02

1.0

1.2

—

Inflammatory diseases of female pelvic organs

2.06

1.01

1.0

1.2

—

Mood [affective] disorders

1.88

1.01

1.5

1.1

—

Other diseases of intestines

1.90

1.01

1.5

1.1

—

Mood disorders

1.87

1.01

1.5

1.1

—

Arthropathies

1.90

1.00

1.1

1.2

—

Diseases of pulp and periapical tissues, including avohilmo

1.90

0.99

1.5

1.1

—

Insulin, intermediate and long-acting

2.21

0.99

1.0

1.2

—

Chronic periodontitis, including avohilmo

1.91

0.98

1.3

1.1

—

Periodontitis

1.91

0.97

1.3

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

1.96

0.97

1.4

1.1

—

Type 2 diabetes, definitions combined

1.82

0.96

1.6

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.81

0.95

1.6

1.1

—

Other and unspecified dermatitis

2.22

0.93

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

1.89

0.93

1.5

1.1

—

Fall on same level involving ice and snow

2.14

0.91

1.0

1.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.14

0.91

1.2

—

Neurotic, stress-related and somatoform disorders

1.84

0.90

1.4

1.1

—

Any reimbursement code in KELA

2.15

0.89

1.3

1.1

—

Anxiety disorders

1.83

0.89

1.4

1.1

—

Ischaemic heart disease, wide definition

1.91

0.88

1.5

1.1

—

Polycystic ovarian syndrome, consortium definition

1.90

0.88

1.0

1.2

—

Carpal tunnel syndrome

2.03

0.88

1.0

1.2

—

Arthrosis

2.06

0.87

1.2

1.1

—

Ischemic heart diseases

1.85

0.86

1.5

1.1

—

Pain (limb, back, neck, head abdominally)

2.00

0.84

1.3

1.1

—

Osteopathies and chondropathies

1.93

0.83

1.0

1.2

—

Gastro-oesophageal reflux disease

1.92

0.83

1.5

1.1

—

Caries of dentine, including avohilmo

1.78

0.82

1.3

1.1

—

Anxiety disorders, excluding more controls

1.73

0.81

1.5

1.1

—

Pure hypercholesterolaemia

1.86

0.79

1.0

1.2

—

Other dorsopathies, not elsewhere classified

1.81

0.79

1.1

—

Dorsopathies

1.76

0.78

1.4

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.75

0.78

1.2

1.1

—

Type 2 diabetes, strict (exclude DM1)

1.76

0.78

1.6

1.1

—

Degeneration of macula and posterior pole

2.21

0.77

1.0

1.3

—

Hernia

1.72

0.76

1.6

1.1

—

Insomnia

1.72

0.76

1.7

1.1

—

Other antidepressants

1.77

0.76

1.5

1.0

—

Sleep disorders

1.67

0.74

1.7

1.1

—

Irregular menses

2.08

0.74

1.0

1.2

—

Type 2 diabetes, definitions combined, including avohilmo

1.64

0.73

1.6

1.1

—

Sciatica+with lumbago

2.00

0.72

1.0

1.1

—

Zoster [herpes zoster]

1.97

0.72

1.2

—

Complications of medical and surgical care

1.74

0.71

1.0

1.2

—

Dizziness and giddiness

1.73

0.70

1.0

1.2

—

Disorders of sclera, cornea, iris and ciliary body

1.92

0.70

1.0

1.2

—

Codes for special purposes

1.92

0.70

1.0

1.2

—

Provisional assignment of new diseases of uncertain etiology

1.92

0.70

1.0

1.2

—

Presence of other functional implants

1.93

0.70

1.2

1.1

—

Other intervertebral disc disorders

1.69

0.68

1.0

1.1

—

Exposure to other specified factors

1.65

0.67

1.0

1.2

—

Disorders of breast

1.82

0.67

1.2

1.1

—

Certain infectious and parasitic diseases

1.67

0.64

1.3

1.2

—

Other disorders of ear

1.69

0.64

1.0

1.2

—

Codeine

1.67

0.64

1.3

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.72

0.63

1.0

1.2

—

Fracture of lower leg, including ankle

1.71

0.63

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

1.64

0.62

1.1

1.2

—

Diabetes mellitus in pregnancy

0.00

0.62

0.0

1.1

—

Cholelithiasis

1.62

0.62

1.4

1.1

—

Gestational diabetes (for exclusion)

0.00

0.61

0.0

1.1

—

Disorders of conjunctiva

1.60

0.61

1.3

1.2

—

Dyspnoea

1.60

0.61

1.0

1.2

—

Cholelithiasis, broad definition with cholecystitis

1.58

0.61

1.4

1.1

—

Peripheral artery disease

0.00

0.61

0.0

1.3

—

Artrosis, including avohilmo

1.56

0.60

1.5

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.79

0.59

1.7

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.57

0.59

1.0

1.2

—

Other bacterial diseases

1.54

0.59

1.0

1.2

—

Lower back pain or/and sciatica

1.59

0.58

1.0

1.2

—

Diseases of pulp and periapical tissues and dental caries

1.71

0.58

1.2

1.1

—

Low back pain

1.66

0.56

1.0

1.1

—

Depression or dysthymia

1.66

0.56

1.7

1.1

—

Disorders of gallbladder, biliary tract and pancreas

1.53

0.55

1.4

1.1

—

Benzodiazepine use

1.47

0.54

1.4

1.1

—

Diabetes medication

1.56

0.54

1.5

1.1

—

Major coronary heart disease event

1.62

0.50

1.1

1.2

—

Cholecystectomy

1.48

0.50

1.5

1.1

—

Diseases of the eye and adnexa

1.59

0.50

1.3

1.2

—

Other joint disorders

1.54

0.49

1.4

1.2

—

Constipation

1.51

0.48

1.6

1.1

—

Any mental disorder

1.52

0.47

1.5

1.1

—

Conjunctivitis

1.46

0.47

1.3

1.2

—

Abnormalities of breathing

1.45

0.47

1.1

1.3

—

Malignant neoplasm, wide definition for exclusion

1.42

0.45

1.6

1.0

—

Leiomyoma of uterus

1.67

0.44

1.0

1.1

—

Angina pectoris

1.67

0.44

1.0

1.1

—

Any event in cancer register

1.47

0.44

1.1

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.46

0.43

1.3

1.2

—

Anti-inflammatory and antirheumatic products, non-steroids

0.00

0.43

0.0

1.0

—

Other (not insulin) diabetes medications

1.44

0.43

1.5

1.1

—

Biguanides

1.43

0.43

1.1

—

Benign neoplasms

1.42

0.43

1.6

1.1

—

Lumbar disc prolapse

1.60

0.43

1.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.42

0.42

1.6

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.59

0.42

1.0

1.2

—

Falls/tendency to fall

1.47

0.42

1.2

—

Disorders of lens

1.56

0.42

1.2

1.3

—

Alzheimer disease

0.00

0.42

0.0

1.1

—

Varicose veins

1.51

0.41

1.2

—

Dermatophytosis

1.51

0.41

1.0

1.2

—

Coronary atherosclerosis

1.51

0.41

1.6

1.1

—

Medical observation and evaluation for suspected diseases and conditions

1.50

0.41

1.4

1.0

—

COPD, hospital admissions 1, only main diagnosis

0.00

0.41

0.0

1.3

—

Any dementia

0.00

0.41

0.0

1.2

—

Statin medication

1.48

0.40

1.2

1.0

—

Gingivitis and periodontal diseases

1.41

0.40

1.4

1.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.40

0.0

1.3

—

Care involving use of rehabilitation procedures

1.44

0.39

1.6

1.1

—

Codeine or tramadol medication

1.37

0.39

1.2

—

Dental operations

1.43

0.39

1.2

1.1

—

Fall on same level

1.44

0.39

1.2

—

Sensorineural hearing loss

1.41

0.39

1.0

1.3

—

Conductive and sensorineural hearing loss

1.41

0.38

1.0

1.3

—

Other specific joint derangements/joint disorders

1.40

0.38

1.0

1.2

—

Dentofacial anomalies [including malocclusion]

1.38

0.34

1.0

1.2

—

Viral infections characterized by skin and mucous membrane lesions

1.33

0.31

1.1

1.2

—

Selective serotonin reuptake inhibitors

1.26

0.30

1.6

1.0

—

Dental pulpitis, including avohilmo

1.26

0.30

1.6

1.1

—

COPD/asthma/ILD related infections

1.34

0.29

1.3

1.2

—

COPD/asthma related infections

1.34

0.29

1.3

1.2

—

Acute upper respiratory infections

0.68

0.27

1.0

1.2

—

Diseases of the ear and mastoid process

1.32

0.26

1.0

1.2

—

Injuries to the knee and lower leg

1.22

0.25

1.3

1.1

—

Other diseases of hard tissues of teeth

1.29

0.23

1.2

1.1

—

Diseases of oral cavity, salivary glands and jaws

1.29

0.23

1.2

1.1

—

Neoplasms

1.26

0.23

1.2

1.1

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.00

0.22

0.0

1.0

—

Oxicams

0.00

0.22

0.0

1.0

—

Percutaneous Coronary Intervention

1.23

0.22

1.2

1.1

—

Coronary revascularization (ANGIO or CABG)

1.22

0.22

1.2

1.1

—

Injuries to the ankle and foot

1.23

0.22

1.0

1.2

—

Endocrine, nutritional and metabolic diseases

1.21

0.22

1.2

1.1

—

Pain in throat and chest

1.20

0.22

1.0

1.2

—

Special screening examination for infectious and parasitic diseases

0.00

0.21

0.0

1.0

—

Acute suppurative otitis media

0.00

0.21

0.0

1.2

—

Alzheimer’s disease (Late onset)

0.00

0.21

0.0

1.1

—

Alzheimer’s disease, strict definition

0.00

0.21

0.0

1.1

—

Any dementia, excluding more controls

0.00

0.21

0.0

1.1

—

Peripheral arterial reconstruction

0.00

0.21

0.0

1.2

—

Nasal polyp

0.00

0.21

0.0

1.1

—

Early onset COPD

0.00

0.21

0.0

1.5

—

severe traumatic brain injury, does not include concussion

0.00

0.21

0.0

1.2

—

Fracture of skull and facial bones

0.00

0.21

0.0

1.2

—

Combinations of oral blood glucose lowering drugs

0.00

0.21

0.0

1.1

—

Nontoxic goitre/thyroid nodule

0.00

0.21

0.0

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.00

0.21

0.0

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

0.00

0.21

0.0

1.1

—

Medical treatment for female infertility

0.00

0.21

0.0

1.1

—

Atopic dermatitis, strict definition

0.00

0.21

0.0

1.2

—

Atopic dermatitis, strict definition with reimbursement

0.00

0.21

0.0

1.1

—

Use of other anti-dementia drugs

0.00

0.21

0.0

1.1

—

Use of memantine

0.00

0.21

0.0

1.1

—

Gonarthrosis,primary

1.27

0.21

1.0

1.2

—

Malignant neoplasm

1.27

0.21

1.7

1.0

—

Acute alcohol intoxication

0.00

0.21

0.0

1.4

—

Myocardial infarction, unclassifiable

0.00

0.20

0.0

1.2

—

Maternal care for other conditions predominantly related to pregnancy

0.00

0.20

0.0

1.1

—

Dorsalgia

1.24

0.20

1.0

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

0.00

0.20

0.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.22

0.18

1.0

1.2

—

Complications of surgical and medical care, not elsewhere classified

1.14

0.17

1.0

1.2

—

Use of hypnotics and sedatives

1.21

0.17

1.4

1.1

—

Persons encountering health services for specific procedures and health care

1.17

0.17

1.4

1.1

—

Accidents

1.19

0.10

1.4

1.1

—

Other external causes of accidental injury

1.19

0.10

1.4

1.1

—

Emergency coronary revascularization (for ACS)

1.13

0.10

1.2

—

Triptan medication for migraine, single purchase ok

1.06

0.09

1.4

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.06

0.09

1.4

1.1

—

Psychiatric diseases

1.11

0.09

1.7

1.0

—

Chronic diseases of tonsils and adenoids

1.12

0.09

1.0

1.1

—

Caries of enamel

1.11

0.09

1.2

—

Symptoms and signs involving the circulatory and respiratory systems

1.07

0.09

1.2

1.3

—

Symptoms and signs involving the digestive system and abdomen

0.81

0.08

1.6

1.1

—

Hypothyroidism, other/unspecified

0.78

0.08

1.6

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

0.78

0.08

1.6

1.1

—

Intestinal infectious diseases

0.81

0.08

1.0

1.2

—

Asthma, including avohilmo

0.87

0.07

1.1

1.2

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

0.0

1.2

—

Foreign body on external eye

0.00

0.0

1.7

—

Other disorders of the genitourinary system

0.00

0.0

1.2

—

Nontoxic multinodular goitre

0.00

0.0

1.1

—

Myopia

0.00

0.0

1.2

—

Asthma (diagnoses ohter than nonallergic)

0.92

0.00

1.0

1.2

—

Non-allergic asthma (mode)

0.00

0.0

1.1

—

Retinal vascular occlusion

0.00

0.0

1.2

—

Malignant neoplasm of bronchus and lung, including Hilmo

0.00

0.0

1.1

—

Abnormal findings on diagnostic imaging of other body structures

0.00

0.0

1.2

—

Malignant neoplasm of colon

0.00

0.0

1.2

—

Colon adenocarcinoma

0.00

0.0

1.2

—

Familial hypercholesterolemia, with ischemic heart disease

0.00

0.0

1.2

—

Early onset COPD, excluding more controls

0.00

0.0

1.1

—

Erectile dysfunction

0.00

0.0

1.2

—

Non-small cell lung cancer, including Hilmo

0.00

0.0

1.2

—

malignant neoplasm of female genital organs

0.00

0.0

1.1

—

Retinal vascular disorders

0.00

0.0

1.2

—

Other disorders of penis

0.00

0.0

1.2

—

Tooth eruption problems

0.00

0.0

1.2

—

Amputation

0.00

0.0

1.2

—

Pedal cyclist injured in transport accident

0.00

0.0

1.2

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.0

1.0

—

Postmenopausal bleeding

0.00

0.0

1.4

—

Malignant neoplasm of rectum, including Hilmo

0.00

0.0

1.2

—

Thoracic aortic aneurysm

0.00

0.0

1.3

—

Dilated cardiomyopathy

0.00

0.0

1.3

—

Non-small cell lung cancer

0.00

-0.00

0.0

1.2

—

Maternal care for known or suspected malpresentation of fetus

0.00

-0.00

0.0

1.0

—

Colorectal adenocarcinoma

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of bronchus and lung

0.00

-0.00

0.0

1.2

—

Undefined dementia

0.00

-0.00

0.0

1.2

—

Prolonged pregnancy

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

1.1

—

Fenamates

0.00

-0.00

0.0

1.0

—

Hydrocele

0.00

-0.00

0.0

1.2

—

Injuries to the wrist and hand

0.92

-0.00

1.0

1.2

—

L02BB Anti-androgens

0.00

-0.00

0.0

1.0

—

Respiratory insufficiency

0.00

-0.00

0.0

1.2

—

Abnormal spermatozoa

0.00

-0.00

0.0

1.6

—

Abdominal and pelvic pain

0.97

-0.00

1.5

1.1

—

Radiculopathy

0.00

-0.00

0.0

1.2

—

ILD differential diagnosis

0.93

-0.00

1.8

1.1

—

Palmar fascial fibromatosis [Dupuytren]

0.00

-0.00

0.0

1.0

—

Cholecystitis

0.00

-0.00

0.0

1.1

—

Injury of eye and orbit

0.00

-0.00

0.0

1.2

—

Injuries to the neck

0.00

-0.00

0.0

1.3

—

Malignant melanoma

0.00

-0.00

0.0

1.2

—

Acute laryngitis and tracheitis

0.00

-0.00

0.0

1.2

—

Follicular cysts of skin and subcutaneous tissue

0.00

-0.00

0.0

1.2

—

Thiazolidinediones

0.00

-0.00

0.0

1.2

—

Intestinal infectious diseases

0.91

-0.00

1.0

1.2

—

Other diseases of upper respiratory tract

0.99

-0.00

1.6

1.1

—

Acute nasopharyngitis (common cold)

0.00

-0.00

0.0

1.2

—

Hypotension

0.00

-0.00

0.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

0.90

-0.00

1.0

1.2

—

Persons encountering health services in other circumstances, wide

0.95

-0.00

1.0

1.2

—

Hyperparathyroidism

0.00

-0.00

0.0

1.2

—

Follow-up examination after treatment for malignant neoplasms

0.00

-0.00

0.0

1.0

—

Sequelae with surgical and medical care as external cause

0.00

-0.00

0.0

1.2

—

Open wound of lower leg

0.00

-0.00

0.0

1.4

—

Car occupant injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.4

—

Other/unspecified rheumatoid arthritis

0.00

-0.00

0.0

1.2

—

Single delivery by forceps and vacuum extractor

0.00

-0.00

0.0

1.0

—

Eating disorders

0.00

-0.00

0.0

1.2

—

Non-allergic asthma (mode), excluding more controls

0.00

-0.00

0.0

1.1

—

Inguinal or femoral hernia, bilateral

0.00

-0.00

0.0

1.2

—

Familial hypercholesterolemia

0.00

-0.00

0.0

1.2

—

Alcohol abuse, main dg, excluding more controls

0.00

-0.00

0.0

1.2

—

Polycystic ovarian syndrome, broad definition

0.00

-0.00

0.0

1.2

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

-0.00

0.0

1.1

—

Benign neoplasm: Skin of eyelid, including canthus

0.00

-0.00

0.0

1.2

—

Alcohol abuse, main dg

0.00

-0.00

0.0

1.3

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

0.00

-0.00

0.0

1.1

—

Pleural plaque

0.00

-0.00

0.0

1.2

—

Acute pharyngitis

0.00

-0.00

0.0

1.2

—

COPD differential diagnosis

0.93

-0.00

1.8

1.1

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

-0.00

0.0

1.2

—

Malignant neoplasm of colon, including Hilmo

0.00

-0.00

0.0

1.1

—

Hypo-osmolality and hyponatraemia

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of bladder, including Hilmo

0.00

-0.00

0.0

1.2

—

Lung cancer and mesothelioma

0.00

-0.00

0.0

1.1

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

1.1

—

Other female pelvic inflammatory diseases

0.00

-0.00

0.0

1.2

—

Schizophrenia

0.00

-0.00

0.0

1.2

—

Acute alcohol intoxication, ICD10

0.00

-0.00

0.0

1.6

—

Malignant melanoma of skin

0.00

-0.00

0.0

1.2

—

Cervicobrachial syndrome

0.00

-0.00

0.0

1.1

—

Degenerative macular diseases

0.00

-0.00

0.0

1.2

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

1.0

—

Salpingitis and oophoritis

0.00

-0.00

0.0

1.2

—

Inflammatory diseases of prostate (prostatitis)

0.00

-0.00

0.0

1.2

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

0.00

-0.00

0.0

1.2

—

Asthma (mode)

0.99

-0.00

1.0

1.1

—

Use of donepezil

0.00

-0.00

0.0

1.1

—

Unspecified dementia

0.00

-0.00

0.0

1.1

—

Retinal detachment with retinal break

0.00

-0.00

0.0

1.4

—

Artificial joint operation, meniscal resection

1.01

-0.00

1.6

1.1

—

Colorectal cancer

0.00

-0.00

0.0

1.1

—

Vascular dementia

0.00

-0.00

0.0

1.2

—

Inguinal hernia, bilateral

0.00

-0.00

0.0

1.2

—

Peripheral artery operations in Hilmo

0.00

-0.00

0.0

1.1

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Acanthocytes/1000 erythrocytes in Blood by Light microscopy

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS